Radiotherapy for the treatment of locally advanced and metastatic prostate cancer

Danny Y Song, Salma K. Jabbour, Theodore DeWeese

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The value of radiotherapy in the treatment of prostate cancer has been recognized for nearly a century. The use of transurethral radium was first described in 1911 by Pasteau and Degrais.1 In 1930, Smith and Pierson described the utility of high voltage X-ray therapy in the treatment of prostate cancer, and, in 1930, Widmann subsequently noted an improvement in survival for patients with advanced prostate cancer treated with kilovoltage X-rays.2,3 Prior to the advent of prostate-specific antigen (PSA), the majority of patients were diagnosed based on clinically evident disease, which was often more advanced than the presentations commonly seen today. The activity of radiation in prostate cancer was evident by its effect on large palpable tumors that resolved following treatment. Widespread screening for prostate cancer has led to an increasing frequency of the disease being detected in its early stages, but there remains a significant proportion of patients who are diagnosed with locally advanced or even metastatic disease.

Original languageEnglish (US)
Title of host publicationProstate Cancer
Subtitle of host publicationPrinciples and Practice
PublisherCRC Press
Pages1005-1024
Number of pages20
ISBN (Electronic)9780203624326
ISBN (Print)9781841844589
StatePublished - Jan 1 2005
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Radiotherapy for the treatment of locally advanced and metastatic prostate cancer'. Together they form a unique fingerprint.

Cite this